The intake of flavonoids and carotid atherosclerosis: The Kuopio Ischaemic Heart Disease Risk Factor Study

British Journal of Nutrition

Volumn 98, Issue 4, 2007, Pages 814-818

  Mursu, Jaakko ^a   Nurmi, Tarja ^a   Tuomainen, Tomi Pekka ^a   Ruusunen, Anu ^a   Salonen, Jukka T ^a,b   Voutilainen, Sari ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Oy Jurilab Ltd   (Finland)

Author keywords

Atherosclerosis; Common carotid artery intima media thickness; Cross sectional study; Flavonoids; Kuopio Ischaemic Heart Disease Risk Factor Study

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIDIN DERIVATIVE; ASCORBIC ACID; FLAVAN 3 OL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYPHENOL DERIVATIVE; SATURATED FATTY ACID; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; OXYGEN TENSION; PREVALENCE; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; ATHEROSCLEROSIS; BLOOD GLUCOSE; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CROSS-SECTIONAL STUDIES; FINLAND; FLAVONOIDS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 34748907232     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507744410     Document Type: Article

References (35)

1. Ness AR & Powles JW (1997) Fruit and vegetables, and cardiovascular disease: A review. Int J Epidemiol 26, 1-13.
2. Bazzano LA, Serdula MK & Liu S (2003) Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr Atheroscler Rep 5, 492-499.
3. Bravo L (1998) Polyphenols: Chemistry, Dietary sources, Metabolism, and Nutritional significance. Nutr Rev 56, 317-333.
4. Hertog M, Sweetnam P, Fehily AM, Elwood PC & Kromhout D (1997) Antioxidant flavonols and ischemic heart disease in Welsh population of men: The Caerphilly study. Am J Clin Nutr 65, 1489-1494.
5. Youchum L, Kushi LH, Meyer K & Folsom AR (1999) Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149, 943-949.
6. Rimm E, Katan M, Ascherio A, Stampfer MJ & Willet WC (1996) Relation between intake of flavonoids and risk of coronary heart disease in male health professionals. Ann Intern Med 125, 384-389.
7. Knekt P, Jr̈vinen R, Reunanen A & Maatela J (1996) Flavonoid intake and coronary mortality in Finland: A cohort study. BMJ 312, 478-481.
8. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB & Kromhout D (2001) Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: The Zutphen Elderly Study. Am J Clin Nutr 74, 227-232.
9. Arts IC, Jacobs DRJ, Harnack LJ, Gross M & Folsom AR (2001) Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiol 12, 668-675.
10. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB & Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study. Lancet 342, 1007-1011.
11. Hertog MG, Feskens EJ & Kromhout D (1997) Antioxidant flavonols and coronary heart disease risk. Lancet 349, 699.
12. Hirvonen T, Virtamo J, Korhonen P, Albanes D & Pietinen P (2000) Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 31, 2301-2306.
13. Hirvonen T, Pietinen P, Virtanen M, Ovaskainen ML, Häkkinen S, Albanes D & Virtamo J (2001) Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiol 12, 62-67.
14. Keli SO, Hertog MGL, Feskens EJM & Kromhout D (1996) Dietary flavonoids, antioxidant vitamins and incidence of stroke. Arch Intern Med 154, 637-642.
15. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T & Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560-568.
16. Sesso HD, Gaziano JM, Liu S & Buring JE (2003) Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 77, 1400-1408.
17. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A & Witteman JC (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: The Rotterdam Study. Am J Clin Nutr 75 880-886.
18. Dwyer J & Peterson JJ (2002) Measuring flavonoid intake: Need for advanced tools. Public Health Nutr 5, 925-930.
19. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA & Jacobs DRJ (2007) Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85 895-909.
20. Salonen JT (1988) Is there continuing need for longitudinal epidemiological research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20, 46-50.
21. Lakka TA, Laukkanen JA, Rauramaa R, Salonen R, Lakka H-M, Kaplan GA & Salonen JT (2001) Cardiorespiratory fitness and the progression of carotid atherosclerosis in middle-aged men. Ann Intern Med 134 12-20.
22. Salonen JT, Seppanen K, Lakka TA, Salonen R & Kaplan GA (2000) Mercury accumulation and accelerated progression of carotid atherosclerosis: A population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148, 265-273.
23. Salonen R, Haapanen A & Salonen JT (1991) Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography: Inter- and intra-observer variability. Ultrasound Med Biol 17, 225-230.
24. Willett W & Stampfer M (1998) Implications of total energy intake for epidemiologic analyses. In Nutritional epidemiology, chapter 11, pp. 273-301 [W Willett, editor]. New York: Oxford University Press.
25. Kähkönen MP, Hopia AI & Heinonen M (2001) Berry phenolics and their antioxidant activity. J Agric Food Chem. 49, 4076-4082.
26. Greenland P, Abrams J, Aurigemma GP, et al. (2000) Prevention Conference V: Beyond seIondary prevention: identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101, 16-22.
27. Lorenz MW, Markus HS, Bots ML, Rosvall M & Sitzer M (2007) Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness. A Systematic Review and Meta-Analysis. Circulation Epublication ahead of print version.
28. Huxley RR & Neil HA (2003) The relation between dietary flavonol intake and coronary heart disease mortality: A meta-analysis of prospective cohort studies. Eur J Clin Nutr 57, 904-908.
29. Hodgson JM, Burke V & Puddey IB (2005) Acute effects of tea on fasting and postprandial vascular function and blood pressure in humans. J Hypertens 23, 47-54.
30. Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I & Stefanadis C (2005) Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 18, 785-791.
31. Hayek T, Furhman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A & Aviram M (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficeint mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation aggregation. Arterioscler Thromb Vasc Biol 17, 2744-2752.
32. Fuhrman B, Volkova N, Coleman R & Aviram M (2005) Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr 135, 722-728.
33. Williamson G & Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243-255.
34. Vita JA (2005) Polyphenols and cardiovascular disease: Effects on endothelial and platelet function. Am J Clin Nutr 81, 292-297.
35. Scalbert A & Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S-2085S.